News articles about Varian Medical Systems (NYSE:VAR) have trended positive recently, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.29 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 45.7475022378311 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the news headlines that may have effected Accern Sentiment’s analysis:

Shares of Varian Medical Systems (NYSE VAR) opened at 105.31 on Friday. Varian Medical Systems has a 52-week low of $75.20 and a 52-week high of $107.08. The firm’s 50-day moving average price is $101.00 and its 200-day moving average price is $95.84. The stock has a market capitalization of $9.67 billion, a P/E ratio of 34.66 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million during the quarter, compared to analyst estimates of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company’s revenue was up 3.0% compared to the same quarter last year. During the same period last year, the company posted $1.00 EPS. Equities analysts forecast that Varian Medical Systems will post $3.93 earnings per share for the current fiscal year.

A number of analysts recently weighed in on VAR shares. Citigroup Inc. upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Jefferies Group LLC restated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. BTIG Research upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 price target on the stock in a research note on Monday, May 8th. BidaskClub downgraded Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 29th. Finally, Zacks Investment Research upgraded Varian Medical Systems from a “hold” rating to a “buy” rating and set a $117.00 price target on the stock in a research note on Tuesday, June 27th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. Varian Medical Systems currently has an average rating of “Hold” and an average price target of $96.28.

TRADEMARK VIOLATION NOTICE: “Varian Medical Systems (VAR) Earning Favorable Press Coverage, Report Finds” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/02/varian-medical-systems-var-earning-favorable-press-coverage-report-finds.html.

In other news, Director Timothy E. Guertin sold 16,000 shares of the firm’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $103.22, for a total value of $1,651,520.00. Following the completion of the sale, the director now owns 2,161 shares of the company’s stock, valued at $223,058.42. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Mark R. Laret sold 1,428 shares of the firm’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $103.47, for a total value of $147,755.16. Following the completion of the sale, the director now directly owns 3,289 shares of the company’s stock, valued at approximately $340,312.83. The disclosure for this sale can be found here. In the last ninety days, insiders sold 83,911 shares of company stock valued at $8,607,331. 0.91% of the stock is currently owned by insiders.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.